Jonathan W. Dickerson

Biased mGlu 5 -Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu 5 Modulation of NMDAR Currents

Jerri M. Rook, Zixiu Xiang, Xiaohui Lv et al. · Neuron · 2015 · 129 citations · Full text

Life Sciences, Neuroscience, Pharmacology +16

Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model

Ayan Ghoshal, Jerri M. Rook, Jonathan W. Dickerson et al. · Neuropsychopharmacology · 2015 · 107 citations · Full text

Life Sciences, Neuroscience, Pharmacology +14

The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease

Carrie K. Jones, Michael Bubser, Analisa D. Thompson et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 100 citations

Medicine, Neuroscience, Pharmacology +17

Stress exacerbates experimental Parkinson’s disease

Ann M. Hemmerle, Jonathan W. Dickerson, James P. Herman et al. · Molecular Psychiatry · 2013 · 81 citations

Life Sciences, Neurology, Neuroscience +12

M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition

Sean P. Moran, Jonathan W. Dickerson, Hyekyung P. Cho et al. · Neuropsychopharmacology · 2018 · 81 citations

Life Sciences, Neuroscience, Pharmacology +15